{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:05:52Z","timestamp":1779771952983,"version":"3.53.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type A insulin resistance syndrome (TAIRS) is a rare inherited disorder caused by mutations in the insulin receptor (INSR) gene. It is characterized by severe insulin resistance, hyperandrogenism, and acanthosis nigricans. Its clinical manifestations overlap with those of polycystic ovary syndrome (PCOS), making it prone to misdiagnosis, particularly in adolescent females. Currently, the diagnosis of TAIRS relies on clinical evaluation and genetic confirmation, while long-term management strategies remain limited and challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      We report a 12-year-old female proband who presented with severe hyperinsulinemia, hyperandrogenism (hirsutism), acanthosis nigricans, and polycystic ovarian changes despite a non-obese phenotype. Whole-exome sequencing identified a\n                      <jats:italic>de novo<\/jats:italic>\n                      heterozygous variant in the INSR gene (NM_000208.4:c.3328G&amp;gt;C, p.Asp1110His). This variant was absent from the ClinVar and gnomAD databases and was predicted to be deleterious by in silico analyses. Family segregation analysis demonstrated that neither parent nor the proband\u2019s brother carried the variant, consistent with a\n                      <jats:italic>de novo<\/jats:italic>\n                      event. According to ACMG guidelines, this variant was classified as \u201clikely pathogenic,\u201d providing a molecular basis for the diagnosis of TAIRS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This case is attributed to a\n                      <jats:italic>de novo<\/jats:italic>\n                      p.Asp1110His variant in INSR. The diagnostic process highlights the importance of genetic testing in adolescents presenting with atypical PCOS features, particularly severe hyperinsulinemia and non-obesity. This report expands the known pathogenic variant spectrum of the INSR gene and reviews TAIRS cases reported since 2010. It further emphasizes that long-term management of TAIRS requires individualized, multidisciplinary strategies, including pharmacological and medical nutrition therapy in addition to lifestyle interventions. Type A insulin resistance syndrome (TAIRS) is a rare genetic disorder resulting from mutations in the insulin receptor (INSR) gene and may be inherited in either an autosomal dominant or autosomal recessive manner. The disorder is primarily characterized by severe insulin resistance, accompanied by clinical features such as hyperandrogenism, hirsutism, and acanthosis nigricans. In female patients, polycystic ovary syndrome (PCOS) is a common associated condition. Early diagnosis and intervention are crucial, as they can delay the onset of precocious puberty and reduce the risk of metabolic and endocrine complications, as well as related neoplasms. This article reports a TAIRS proband carrying a novel mutation, with the aim of providing a reference for the clinical diagnosis and management of this rare condition.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1840942","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:43:32Z","timestamp":1779770612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a De Novo INSR c.3328G&gt;C mutation"],"prefix":"10.3389","volume":"17","author":[{"given":"Chunmin","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Quanzhou Hospital of Traditional Chinese Medicine","place":["Quanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Quanzhou Hospital of Traditional Chinese Medicine","place":["Quanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanxing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Quanzhou Hospital of Traditional Chinese Medicine","place":["Quanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Quanzhou Hospital of Traditional Chinese Medicine","place":["Quanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-022-00570-5","article-title":"New classification and diagnostic criteria for insulin resistance syndrome","volume":"13","author":"Ogawa","year":"2022","journal-title":"Diabetol Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2021-0305","article-title":"Type A insulin resistance syndrome due to a novel heterozygous c.3486_3503del (p.Arg1163_Ala1168del) INSR gene mutation in an adolescent girl and her mother","volume":"68","author":"Koca","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-22-0362","article-title":"A family with type A insulin resistance syndrome caused by a novel insulin receptor mutation","volume":"2023","author":"Horikawa","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000525223","article-title":"Identification of a novel mutation in patients with type A insulin resistance syndrome","author":"Zhao","year":"2022","journal-title":"Hum Hered"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2023.2022-12-10","article-title":"Diazoxide-unresponsive hyperinsulinemic hypoglycaemia in a preterm infant with heterozygous insulin receptor gene mutation","volume":"17","author":"Poon","year":"2023","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2244106.053","article-title":"A case of type A insulin resistance syndrome in a 14-year-old adolescent girl without common clinical features","volume":"28","author":"Lee","year":"2023","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8878149","article-title":"A new mutation of the INSR gene in a 13-year-old girl with severe insulin resistance syndrome in China","volume":"2021","author":"Jin","year":"2021","journal-title":"BioMed Res Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.895424","article-title":"Case report: A Chinese family of type A insulin resistance syndrome with diabetes mellitus, with a novel heterozygous missense mutation of the insulin receptor gene","volume":"13","author":"You","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149934","article-title":"A de novo INSR variant in type A insulin resistance syndrome: familial investigation and genetic implications","volume":"979","author":"Lin","year":"2025","journal-title":"Gene"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0114","article-title":"Monogenic diabetes due to an INSR mutation in a child with severe insulin resistance","volume":"2022","author":"Sanderson","year":"2022","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-24-0087","article-title":"Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)","volume":"2025","author":"Prehn","year":"2025","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-023-01526-x","article-title":"A multicenter, open-label, single-arm trial of the efficacy and safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-01)","volume":"15","author":"Hirota","year":"2024","journal-title":"Diabetes Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13241","article-title":"Long-term efficacy of the sodium-glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome","volume":"11","author":"Nagashima","year":"2020","journal-title":"J Diabetes Investig"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12659","article-title":"Successful pregnancy outcomes in a patient with type A insulin resistance syndrome","volume":"32","author":"Enkhtuvshin","year":"2015","journal-title":"Diabetes Med"},{"key":"B15","article-title":"Clinical study of metformin in non-diabetic children with obesity and hyperinsulinemia","volume":"17","author":"Chen","year":"2019","journal-title":"J China Prescription Drug"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.16835\/j.cnki.1000-9817.2025299","article-title":"Association of metabolic score for insulin resistance with bone mineral content and bone metabolic markers among adolescents","volume":"46","author":"Liu","year":"2025","journal-title":"Chin J Sch Health"},{"key":"B17","first-page":"119","article-title":"Research progress of metformin in the field of anti-aging","volume":"63","author":"Ji","year":"2025","journal-title":"China Modern Doctor"},{"key":"B18","first-page":"59","article-title":"Improvement effects and mechanism of potato resistant starch on insulin resistance in HepG2 cells","volume":"36","author":"Li","year":"2025","journal-title":"China Food Additives"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136389","article-title":"Potato resistant starch improves type 2 diabetes by regulating inflammation, glucose and lipid metabolism and intestinal microbial environment","volume":"281","author":"Liu","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/09540105.2022.2071846","article-title":"Banana starch intervention a meliorates diabetes-induced mood disorders via modulation of the gut microbiota-brain the axis in diabetic rats","volume":"33","author":"Bai","year":"2022","journal-title":"Food Agric Immunol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1840942\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:43:59Z","timestamp":1779770639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1840942\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":20,"alternative-id":["10.3389\/fendo.2026.1840942"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1840942","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"1840942"}}